| Document Type
|
:
|
BL
|
| Record Number
|
:
|
695219
|
| Doc. No
|
:
|
b517408
|
| Title & Author
|
:
|
Anticancer drug development guide : : preclinical screening, clinical trials, and approval /\ edited by Beverly A. Teicher, Paul A. Andrews
|
| Edition Statement
|
:
|
2nd ed
|
| Publication Statement
|
:
|
Totowa, N.J. :: Humana Press,, c2004
|
| Series Statement
|
:
|
Cancer drug discovery and development
|
| Page. NO
|
:
|
xiv, 450 p. :: ill. ;; 26 cm. ++ 1 CD-ROM (4 3/4 in.)
|
| ISBN
|
:
|
1588292282 (alk. paper)
|
|
|
:
|
: 1592597394 (e-book)
|
| Bibliographies/Indexes
|
:
|
Includes bibliographical references and index
|
| Contents
|
:
|
Drug development in Europe: the academic perspective / Chris Twelves ... [et al.] -- The phase III clinical cancer trial / Ramzi N. Dagher and Richard Pazdur -- Assessing tumor-related symptoms and health-related quality of life in cancer clinical trials: a regulatory perspective / Judy H. Chiao, Grant Williams, and Donna Griebel -- The role of the oncology drug advisory committee in the FDA review process for oncologic products / Leslie A. Vaccari -- FDA role in cancer drug development and requirements for approval / Susan Flamm Honig
|
|
|
:
|
High-volume screening / Michel Pagä -- High-throughput screening in industry / Michael D. Boisclair ... [et al.] -- The NCI human tumor cell line (60-cell) screen: concept, implementation, and applications / Michael R. Boyd -- Human tumor screening / Axel-R. Hanauske, Susan G. Hilsenbeck, and Daniel D. Von Hoff -- Murine L1210 and P388 leukemias / William R. Waud -- In vivo methods for screening and preclinical testing: use of rodent solid tumors for drug discovery / Thomas Corbett ... [et al.] -- Human tumor xenograft models in NCI drug development / Michael C. Alley ... [et al.] -- Specialized in vitro/in vivo procedures employed by the NCI in preclinical drug evaluations / Melinda G. Hollingshead ... [et al.] --
|
|
|
:
|
Patient-like orthotopic metastatic models of human cancer / Robert M. Hoffman -- Preclinical models for combination therapy / Beverly A. Teicher -- Models for biomarkers and minimal residual tumor / Beverly A. Teicher -- Spontaneously occurring tumors in companion animals as models for drug development / David M. Vail and Douglas H. Thamm -- Nonclinical testing: from theory to practice / Denis Roy and Paul A. Andrews -- Nonclinical testing for oncology drug products / Paul A. Andrews and Denis Roy -- Nonclinical testing for oncology biologic products / Carolyn M. Laurenìot, Denis Roy, and Paul A. Andrews --
|
|
|
:
|
Working with the national cancer institute / Paul Thambi and Edward A. Sausville -- Phase I trial design and methodology for anticancer drugs / Patrick V. Acevedo, Deborah L. Toppmeyer, and Eric H. Rubin -- Phase II trials: conventional design and novel strategies in the era of targeted therapies / Keith T. Flaherty and Peter J. O'Dwyer --
|
| Subject
|
:
|
Antineoplastic agents-- Development
|
| Dewey Classification
|
:
|
616.99/4061
|
| LC Classification
|
:
|
RC271.C5A6722 2004
|
|
|
:
|
RC271.C5A6722 2004
|
| NLM classification
|
:
|
2004 D-110
|
|
|
:
|
QV 269A62953 2004
|
| Added Entry
|
:
|
Andrews, Paul A
|
|
|
:
|
Teicher, Beverly A.,1952-
|